Dr. Daniel Arthur Wollin, MD

Dr. Wollin practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Wollin's NPI, 1629360714, was assigned on May 6, 2011. Dr. Wollin graduated from University of Chicago, Pritzker School of Medicine in 2011. Dr. Wollin holds Massachusetts license 276922.

Dr. Wollin's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Wollin's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Wollin is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Wollin to 3 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wollin practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Wollin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Wollin's licenses on file in 2 states: Massachusetts and North Carolina.

CMS data shows 993 Medicare services from Dr. Wollin across 17 procedure codes in 2024, for 441 Medicare patients. Medicare paid $100,301 for them.

CMS counts 441 Medicare patients who saw Dr. Wollin in 2024. The largest group is 65 to 74, with 212 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wollin's median patient age at 71, with 29% women.

In 2024, Dr. Wollin wrote 595 Medicare Part D claims for 174 patients. 85% of them were for generic drugs. CMS names the drug for 526 of them, across 11 drugs with 11 or more claims each, at $61,255 in total drug cost. In 2023, CMS named 509 claims across 8 drugs.

Dr. Wollin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wollin as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Wollin, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Wollin, published from 2023 to 2025. 2023 was the busiest year, with 3. Dr. Wollin has published most often in J Endourol. Dr. Wollin's most frequent co-authors are John R. Asplin, MD, Brittany Deborah Berk, MD and David S. Goldfarb, MD.

CMS Open Payments shows 94 general payments to Dr. Wollin from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 92% of the total. Boston Scientific Corporation paid the most, $56,992.

Dr. Wollin graduated from University of Chicago, Pritzker School of Medicine in 2011.